Top Banner
Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou
60

Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Dec 19, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Selection of Clinical Trials:Knowledge Representation and Acquisition

Committee:

Eugene Fink

Lawrence O. Hall

Dmitry B. Goldgof

Savvas Nikiforou

Page 2: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Automated Matching of Patients to Clinical Trials

Faculty:

Lawrence O. Hall

Dmitry B. Goldgof

Eugene Fink

Part of the project:

Students:Lynn FletcherPrinceton KokkuSavvas NikiforouBhavesh GoswamiTim IvanovskiyRebecca Smith

Page 3: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Expert System

The system analyzes a patient’s data and

determines whether the patient is eligible

for Moffitt clinical trials.

Page 4: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Expert System

• Guides a clinician through related questions

• Identifies appropriate medical tests

• Selects matching clinical trials

• Minimizes pain and cost of selection process

Page 5: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Outline

• Previous work

• Eligibility decisions

• Knowledge base

• Knowledge entry

• Experiments

Page 6: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Previous Work

• Medical expert systems

• Knowledge acquisition

• Medical systems at USF

Page 7: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Medical Expert Systems

• If-then rules:

– Mycin (1972), Puff (1977), Centaur (1977)

• Qualitative reasoning:

– Oncocin (1981), Eon (1995), OncoDoc (1998)

• Bayesian networks:

– Hepar (1990), AIDS2 (1990)

Page 8: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Knowledge Acquisition

• Teiresias (1974): Knowledge for Mycin

• Salt (1985): Elevator-design rules

• Opal (1987): Knowledge for Oncocin

• Protégé (1987, 2000):

General-purpose tools for developing

knowledge acquisition interfaces

Page 9: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Medical Systems at USF

Selection of clinical trials for cancer patients

• Bayesian networks (Theocharous)

• Qualitative reasoning (Fletcher and Hall)

No knowledge acquisition tools

Page 10: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Outline

• Previous work

• Eligibility decisions

• Knowledge base

• Knowledge entry

• Experiments

Page 11: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Eligibility Criteria

• Female, older than 30

• No prior surgery

• Breast cancer, stage II or III

Page 12: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Questions

Sex:

Age:

Female

Male

25

Page 13: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Conclusion

Patient is not eligible

Page 14: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Questions

Sex:

Age: 35

Female

Male

Page 15: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Questions

Cancer stage:

Prior surgery? Yes No Unknown

I

II

III

IV

Page 16: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Conclusion

Patient is eligible

Page 17: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Full Functionality

• Orders and groups the questions

• Considers multiple clinical trials

Page 18: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Old System

• A programmer has to code the questions

Page 19: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

New System

• A programmer has to code the questions

• A nurse enters the questions

through a friendly interface

• Problem: Build the interface

Page 20: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Outline

• Previous work

• Eligibility decisions

• Knowledge base

• Knowledge entry

• Experiments

Page 21: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Main Objects

• Questions

• Medical tests

• Eligibility criteria

Page 22: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Types of Questions

• Yes / No / Unknown

• Multiple choice

• Numeric

Page 23: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Examples of Questions

Prior surgery? Yes No Unknown

Cancer stage: I

II

III

IV

Age:

Page 24: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Tests

A medical test answers several questions.

It involves certain pain and cost.

Page 25: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example Test: Name and Cost

Test name:

Cost: 50.00

Pain: 1

Mammogram

Page 26: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example Test: Questions

• Yes / No

Question:

Breast cancer?

Page 27: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example Test: Questions

• Multiple choice

Question:

Cancer stage IIIIIIIV

Options:

Page 28: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example Test: Questions

• Numeric

Question: Tumor size 0 25 0

Min Max Prec

Page 29: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Eligibility Criteria

• A logical expression that determines eligibility for a specific clinical trial

Page 30: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: CriteriaAND

Age > 30

Prior-surgery = NO

OR

Cancer-stage = II

Cancer-stage = III

Page 31: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Outline

• Previous work

• Eligibility decisions

• Knowledge base

• Knowledge entry

• Experiments

Page 32: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Tests and Questions

Adding tests Modifying a test

Adding yes/no questions

Adding multiple choice questions

Adding numeric questions

Deleting questions

Page 33: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Adding Tests

Test name:

Cost: 45.50

Pain: 1

Mammography test

Yes/No M-Choice Numeric Deleting

Adding Modifying

Page 34: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Mammography test

45.5050.00

Modifying a Test

Test name:

Cost:

Pain: 1

Mammogram

Yes/No M-Choice Numeric Deleting

Adding Modifying

Page 35: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Adding Yes/No Questions

Breast cancer?

• Text

Yes/No M-Choice Numeric

Adding Modifying

Deleting

Page 36: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Cancer stage

Adding Multiple Choice Questions

• Text Options

Yes/No M-Choice Numeric

Adding Modifying

IIIIIIIV

Deleting

Page 37: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Adding Numeric Questions

Tumor size

• Text Min Max Prec

250 0

Yes/No M-Choice Numeric

Adding Modifying

Deleting

Page 38: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Deleting Questions

Patient’s age

Cancer stage

Breast cancer?

Tumor size

Yes/No M-Choice Numeric Deleting

Adding Modifying

Page 39: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Cancer stage

Tumor size

Yes/No M-Choice Numeric Delete

Adding Modifying

Deleting Questions

Page 40: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Demo

Page 41: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Eligibility Criteria

Adding eligibility criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Page 42: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Example: Eligibility Criteria

• Female, older than 30

• Breast cancer, stage II

• Post-menopausal or surgically sterilized

Page 43: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Adding Eligibility Criteria

Adding criteria

Selecting tests

001 Clinical trial A

Trial number Trial name

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Page 44: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Selecting Tests

General questions

Blood test

Mammogram

Biopsy

Urine test

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Page 45: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Selecting Questions

I II III IVCancer stage:

Age: From: To:0 15030

Post-menopausal? UnknownNoYes

Surgically sterilized? UnknownNoYes

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Prior surgery? UnknownNoYes

Page 46: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Defining an Expression

Cancer-stage = II

Surgically-sterilized = YES

Post-menopausal = YES

Age > 30

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Page 47: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Defining an Expression

AND

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Cancer-stage = II

Surgically-sterilized = YES

Post-menopausal = YES

Age > 30

Page 48: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Defining an Expression

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Surgically-sterilized = YES

Post-menopausal = YES

AND

Age > 30

Cancer-stage = II

Page 49: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Defining an Expression

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

Surgically-sterilized = YES

AND

Age > 30

OR

Post-menopausal = YES

Cancer-stage = II

Page 50: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Defining an Expression

Adding criteria

Selecting tests

Deleting expressions

Editing questions

Defining an expression

Selecting questions

AND

Age > 30

OR

Post-menopausal = YES

Cancer-stage = II

Surgically-sterilized = YES

Page 51: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Demo

Page 52: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Outline

• Previous work

• Eligibility decisions

• Knowledge base

• Knowledge entry

• Experiments

Page 53: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Experiments

Performance of seven novice users

• Entering tests and questions

• Entering eligibility criteria

Page 54: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

0

20

40

60

80

100

0 1 2 3 4

number of a test set

time

per

ques

tion

(sec

)Entering Tests and Questions

Learning curve

Page 55: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Entering Eligibility Criteria

Learning curve

0

20

40

60

80

100

0 1 2 3 4 5 6 7 8 9 10 11

number of a clinical trial

time

per

ques

tion

(sec

)

Page 56: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Entering Eligibility Criteria

0

200

400

600

800

1000

1200

1400

1600

0 5 10 15 20 25 30 35

number of questions

entr

y tim

e (s

ec)

Page 57: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Summary

• Learning time: 1 hour

• Adding a test: 2 to 10 minutes

• Building a knowledge base for Moffitt

breast-cancer trials: 8 to 10 hours

• Adding eligibility criteria: 30 to 60 minutes

Page 58: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Main Results

• Formal model of selection criteria

• Representation of related knowledge

• Friendly interface for knowledge entry

Page 59: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.

Future Work

• Probabilities of different answers

• Logical connections among questions

• Detection of identical and related questions

Page 60: Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.